Eli Lilly is pushing through 1419.83 as positive late-stage clinical data on Foundayo for sleep apnea gives buyers strong momentum. The clearing of manufacturing bottlenecks also adds fuel to the chart.
Levels on watch
• First upside area to monitor sits at 1445.0
• Secondary objective rests up at 1458.0
• An early pullback floor is noted at 1360.0
The setup comes from crowd insights at CrowdWisdomTrading. If price drops below 1325.0, the bullish thesis breaks down and the setup is invalid.
$LLY #Biotech #StockMarket
Educational research, not personal advice. You place the trade. Not a trading instruction. DYOR.
Levels on watch
• First upside area to monitor sits at 1445.0
• Secondary objective rests up at 1458.0
• An early pullback floor is noted at 1360.0
The setup comes from crowd insights at CrowdWisdomTrading. If price drops below 1325.0, the bullish thesis breaks down and the setup is invalid.
$LLY #Biotech #StockMarket
Educational research, not personal advice. You place the trade. Not a trading instruction. DYOR.